trial - recruiting: Temsirolimus and (Avastin) Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor - Full Text View - ClinicalTrials.gov (Canada)